Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares were up 1.8% on Wednesday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares were traded during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The company has a market cap of C$25.87 million, a PE ratio of -1.07 and a beta of 1.22. The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52. The business’s 50 day moving average is C$0.58 and its two-hundred day moving average is C$0.58.
About Acasti Pharma
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The Role Economic Reports Play in a Successful Investment Strategy
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Retail Stocks Investing, Explained
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
